Efficacy of Shringaveradi Choorna in the Management of Renal Calculi: A Clinical Study with Pre-Post study design
DOI:
https://doi.org/10.70066/jahm.v12i12.1538Keywords:
Renal calculi, mootrasmari, Sringaveradi choornaAbstract
Background: Renal stones are a common health problem, affecting approximately 8-10% of the global population. If left untreated or not treated properly, renal calculi can significantly impair kidney function, and recurrence is also common. Many formulations with asmari bhedaka property have been mentioned in ayurveda literature which are cost effective, devoid of complications and provide wide scope for the successful treatment of mootrasmari. Aim - To evaluate the effect of sringaveradi choorna in reducing the size, signs and symptoms of renal calculi.Materials and methods: the study was a pre and post clinical trial with 23 participants in a single group selected on the basis of inclusion and exclusion criteria. Participants were given 2g sringaveradi choorna twice daily, before food with dadhimanda as anupana for a period of 30 days. Assessment was done on 0th , 15th and 31st day for subjective parameters (pain and tenderness over renal angle, burning micturition ,dysuria) and objective parameters(hematuria, puscells in urine). Renal calculi size and number were assessed before and after the treatment by taking USG(Abd&pelvis). Results: Both subjective and objective parameters were statistically significant with P <0.0001. Size and number of calculi showed significance with p<0.001.Conclusion: On analysing the results it can be concluded that Sringaveradi choorna is effective in reducing the size and number as well as signs and symptoms of renal calculi.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jisma Johny, Benedict P, Aneesh s

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.